PARIS – Biosynex SA signed a binding offer to acquire 100% of the stock in Avalun SAS, a company developing the Labpad in vitro diagnostic device that provides rapid biological test results from small ...
United Arab Emirates : The Biosynex group will be present this year at Arab Health 2022 exhibition. The company, which specializes in the design of medical devices, will present innovative solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results